Drug: Bevacizumab Injury: Decreased appetite Quarter: 2016Q3
Total Records: 46 Number of Pages: 3
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
127360691 | Bevacizumab | Decreased appetite | ROCHE | 64.00 YR | M | 113 KG | 20160913 | US |
127446291 | Bevacizumab | Decreased appetite | ROCHE | 21.00 YR | M | 55 KG | 20160915 | US |
127699001 | Bevacizumab | Decreased appetite | ROCHE | 12.00 YR | F | 28 KG | 20160922 | CA |
127833001 | Bevacizumab | Decreased appetite | ROCHE | 0.00 | 0 | 20160927 | JP | |
127872801 | Bevacizumab | Decreased appetite | ROCHE | 67.00 YR | F | 89 KG | 20160927 | US |
877635412 | Bevacizumab | Decreased appetite | ROCHE | 0.00 | 0 | 20160916 | DE |
Total Records: 46 Number of Pages: 3